Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
ZBAO · Nasdaq · United States · Insurance Agents, Brokers & Service
In shortZhibao Technology Inc. is loss-making.
Financial health
Mixed
Built from five areas over the last five annual reports. Tap an area to see the figures behind it. Bank or insurer: tests that do not apply to them are left out.
| Operating marginShare of each sale left after running the business, before interest and tax. | -19.3% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -22.4% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -139.9% | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -7.5% | n/a |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 0 of 4 | n/a |
Weight in the score: 20%
| Profitable years (last 5) | 2 of 4 | 50/100 |
|---|---|---|
| Years of revenue decline (last 5) | 0 of 4 | 100/100 |
| Revenue growth volatility | 901804.8% | 0/100 |
| Operating margin volatility | 20.4% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 36.8% | 100/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
The last 5 fiscal years from the company's annual reports.
CNY millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 0 | 108 | 142 | 184 | 277 |
| Cost of revenue | – | 61 | 83 | 109 | 163 |
| Gross profit | – | 47 | 59 | 75 | 114 |
| Research & development | – | 7.7 | 9.7 | 15 | 11 |
| Operating income | – | 13 | (45) | 10 | (54) |
| Interest expense | – | 1.4 | 1.2 | 1 | – |
| Pre-tax income | – | 12 | (43) | 19 | (65) |
| Income tax | – | (2.1) | 0.5 | 5.5 | (2.6) |
| Net income | – | 14 | (43) | 13 | (62) |
| Diluted EPS | – | ¥0.54 | −¥1.61 | ¥0.44 | −¥1.94 |
| Diluted shares (millions) | – | 26 | 27 | 30 | 32 |
Not computed: the model does not apply to banks and insurers.
4/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2025 · Data updated Apr 2, 2026